More cardiologists will monitor C-reactive protein (CRP) levels

February 2005

More cardiologists will monitor C-reactive protein (CRP) levels.

Some are asking if high-sensitivity CRP can be used to titrate statin therapy in high-risk patients.

Some acute coronary syndrome patients seem to benefit when statins are used to lower hs-CRP below 2 mg/L. This might reduce the risk of recurrent stroke or MI, regardless of LDL levels.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote